Bladder issues are one of those symptoms of multiple sclerosis (MS) that nobody really prepares you for. People often talk about mobility problems, fatigue, or vision changes — not the sudden, urgent need to find a bathroom or the constant awareness of the one closest to you. They don’t…
People with multiple sclerosis (MS) have a nearly fivefold increased risk of developing dementia compared with those without the disease, according to a real-world study in Taiwan. Treatment with disease-modifying therapies significantly reduced the risk for neurodegenerative dementias, or dementias associated with the loss of brain cells, the…
Myelin-making cells in some areas of the brain were more resistant to injury in a mouse model of myelin damage than the same cells in other brain regions. Researchers created detailed, brain-wide maps showing exactly where myelin-making cells, known as oligodendrocytes, are located in the brain. Using these maps, they…
The Accelerated Cure Project for Multiple Sclerosis (ACP) has launched a new community-led initiative designed to ensure that people from underrepresented multiple sclerosis (MS) communities help set priorities for future MS research. sp The initiative, called Prioritized Research Agenda Development and Advancement (PRADA), creates a…
In real-world clinical practice, Ocrevus (ocrelizumab) showed sustained effectiveness in people with relapsing forms of multiple sclerosis (MS), with most patients remaining free from long-term worsening of disability over four years, according to a new study. Relapse rates and MRI disease activity were also low during follow-up. At…
Get regular updates to your inbox.
